Frühgeborenenretinopathie
Crossref DOI link: https://doi.org/10.1007/s00347-018-0683-3
Published Online: 2018-03-07
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krohne, T. U.
Text and Data Mining valid from 2018-03-07
Article History
First Online: 7 March 2018
Interessenkonflikt
: T.U. Krohne: Alimera Sciences, Bayer, Heidelberg Engineering, Novartis.